PT  - JOURNAL ARTICLE
AU  - Nina Schiller
AU  - Anastasia Magoulopoulou
AU  - Florian Cymer
AU  - Gunnar Von Heijne
TI  - Mutational analysis of the human Xbp1 translational arrest peptide and construction of arrest-enhanced variants
AID  - 10.1101/201913
DP  - 2017 Jan 01
TA  - bioRxiv
PG  - 201913
4099  - http://biorxiv.org/content/early/2017/10/11/201913.short
4100  - http://biorxiv.org/content/early/2017/10/11/201913.full
AB  - Xbp1, a protein involved in the unfolded protein response, is a rare example of a mammalian protein that contains a well-defined translational arrest peptide (AP). In order to define the critical residues in the Xbp1u AP, and to search for variants with stronger arrest potency than the wildtype Xbp1u AP, we have carried out a full mutagenesis scan where each residue in the AP was replaced by the other 19 natural amino acids. We find that 10 of the 21 mutagenized positions are optimal already in the wildtype Xbp1 AP, while certain mutations in the remaining residues lead to a strong increase in the arrest potency. Xbp1 has thus evolved to induce an intermediate level of translational arrest, and versions with much stronger arrest efficiency exist. We further show Xbp1-induced translational arrest is reduced in response to increased tension in the nascent chain, making it possible to carry out studies in mammalian systems of cotranslational processes such as membrane protein assembly and protein folding by using suitable Xbp1 AP variants as “force sensors”, as has been done previously in E. coli using bacterial APs.